VERACYTE, INC. director Holstein Jens sold 5,000 shares at $40.95 per share on 2026-09-14, leaving 27,471 shares. The transaction gives investors a specific view of one director’s reduced personal holding, with the sale equal to about 15.4% of Jens’s prior shares holding in VERACYTE, INC.
Key Highlights
- The transaction carried SEC code S.
- Holstein Jens held 27,471 VERACYTE, INC. Shares after the transaction.
- The sale represented about 15.4% of Jens’s prior shares holding.
VERACYTE, INC. (NASDAQ: VCYT) director Holstein Jens sold 5,000 shares on 14 September 2026. The transaction was executed at $40.95 per share.
$40.95 Per Share Transaction
The sale covered 5,000 shares. Following the transaction, Jens’s ownership stood at 27,471 shares. The transaction date was 14 September 2026.
15.4% of Prior Holding The transaction represented about 15.4% of
Holstein Jens’s prior shares holding in VERACYTE, INC. That percentage is tied to the director’s shares held before the transaction. The reported post-transaction position was 27,471 shares.
FAQs
Q: How many Veracyte shares did Holstein Jens sell?
A: Holstein Jens sold 5,000 VERACYTE, INC. Shares at $40.95 per share on 14 September 2026. The transaction was classified with code S.
Q: How many shares did Holstein Jens own after the Veracyte sale?
A: Holstein Jens owned 27,471 VERACYTE, INC. Shares after the transaction. He is identified as a director of the company, and the filing reports this as his post-transaction ownership.
Q: What percentage of Holstein Jens’s Veracyte holding did the sale represent?
A: The transaction represented about 15.4% of Holstein Jens’s prior shares holding in VERACYTE, INC. The percentage refers to his position before the sale.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.